Gallagher Duncan
- SEC CIK
- 0001780880
No open-market purchases or sales filed in the past year.
Current role at each company
- HCAT Health Catalyst, Inc.Directoras of Feb 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gallagher Duncan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 (view filing) | Dec 30, 2024 | 3 days | Gallagher DuncanDirector | SSale | −4.50K | $6.93 | −$31.2K | −6.0%69.9K after | 10b5-1 |
| Dec 27, 2024 (view filing) | Dec 23 | 4 days | Gallagher DuncanDirector | SSale | −4.50K | $6.98 | −$31.4K | −5.7%74.4K after | 10b5-1 |
| Aug 19, 2022 (view filing) | Aug 18-19 | 1 day | Gallagher DuncanDirector | PPurchase | +15.0K | $11.66 | +$175.0K | +73.5%35.4K after | 2 lots |